The role of intracellular esterification in budesonide once-daily dosing and airway selectivity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of intracellular esterification in budesonide once-daily dosing and airway selectivity

Published:2003-01 Issue: Volume:25 Page:C28-C41
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Brattsand Ralph,Miller-Larsson Anna

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference76 articles.

1. Global Strategy for Asthma Management and Prevention;Global Initiative for Asthma,1995

2. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma;National Asthma Education and Prevention Program,1997

3. Pocket Guide for Asthma Management and Prevention;Global Initiative for Asthma,1998

4. Global Strategy for Asthma Management and Prevention;Global Initiative for Asthma,2002

5. Anti-inflammatory actions of steroids: Molecular mechanisms;Barnes;Trends Pharmacol Sci.,1993

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effectiveness and safety of inhaled corticosteroid plus long-acting β ₂ -agonist fixed-dose combinations vs. long-acting muscarinic antagonist in bronchiectasis;Expert Review of Clinical Pharmacology;2024-01-26

2. Cortisol Based Glucocorticoids;SpringerBriefs in Molecular Science;2023

3. Comparison of Risk of Pneumonia Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Retrospective Cohort Study;International Journal of Chronic Obstructive Pulmonary Disease;2021-11

4. Comparative Effectiveness and Safety of Different Types of Inhaled Long-Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score-Inverse Probability of Treatment Weighting Cohort Study;Chest;2021-10

5. Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials;Frontiers in Pharmacology;2021-06-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3